1.Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer
2.Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment